Last reviewed · How we verify
NCT07517497
The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs
NA trial testing Vibrolung in Vibration in 60 participants. Currently enrolling.
1 December 2027
Quick facts
| Lead sponsor | Astana Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 1 March 2025 |
| Primary completion | 1 December 2027 |
| Estimated completion | 1 December 2027 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- Vibrolung
Conditions studied
- Vibration — all drugs for Vibration →
- Respiratory Complications — all drugs for Respiratory Complications →
Sponsor
Astana Medical University
Who can join
Adults 60 to 85, any sex, with Vibration or Respiratory Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples. In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm of actions is planned for both groups. VALT sessions will be conducted 4-6 times a day for 5 minutes in combination with treatment according to the protocol for the use of "Vibroacoustic Therapy" of the lungs of the Ministry of Health of the Republic of Kazakhstan. The device's emitters will be applied to the affected areas of the lungs. Since the device has long cords for the emitters and is portable, it is not difficult to change the patient's position and does not require their active participation, which is important for patients on ventilators and with limited mobility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07517497
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vibrolung
Trials testing the same drug.
- NCT05143372 — Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection · NA · completed
- NCT03911947 — Evaluation of the Effectiveness of Vibroacoustic Therapy in the Complex Treatment of Acute Respiratory Failure · NA · completed
Other recruiting trials for Vibration
Currently open trials in the same condition.
- NCT07293676 — IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation · NA · recruiting
- NCT07424066 — Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performa · NA · recruiting
Other Astana Medical University trials
Trials by the same sponsor.
- NCT07038213 — Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients Wit · enrolling by invitation
- NCT05693428 — Influence of Anesthetics on Clinical Outcome During Cardiac Surgery in Adults · NA · completed
- NCT05742789 — Effect of Anesthetics on Troponin I and С-reactive Protein · Phase 1 · completed
- NCT05143372 — Influence of Vibroacoustic Therapy Modes on the Course of Coronavirus Infection · NA · completed
- NCT05695287 — The Effects of Sevoflurane, Isoflurane and Propofol During Cardiac Surgery · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07517497 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Astana Medical University
- Last refreshed: 8 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07517497.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing